What is the appropriate protocol for transitioning a patient from intravenous insulin to subcutaneous basal‑bolus insulin during the early morning hours (1 am–4 am)?

Transitioning from IV to Subcutaneous Insulin During Early Morning Hours (1am-4am)

Administer subcutaneous basal insulin immediately when stopping the IV insulin infusion, regardless of the time, and do not wait until morning—this prevents rebound hyperglycemia and recurrent ketoacidosis. 1

Timing and Dosing Protocol

The transition should occur when:

• Blood glucose is stable ≤180 mg/dL (10 mmol/L) for at least 24 hours 1
• IV insulin infusion rate is ≤3 units/hour (higher rates indicate major insulin resistance and require continued IV therapy) 1
• Patient is resuming oral feeding or has stable nutritional status 1

Calculate Subcutaneous Insulin Dose

Use 50-80% of the total 24-hour IV insulin requirement as your total daily subcutaneous dose:

• Most widely used approach (Avanzini model): Calculate the average hourly IV insulin rate over the preceding 12-24 hours, multiply by 24 to get total daily dose. Give 50% as basal insulin and 50% as rapid-acting insulin divided before meals 1, 2

• Alternative approach: Use 80% of the 24-hour IV insulin total as basal insulin, with additional rapid-acting insulin at first meal 1

For a patient receiving 1.5 units/hour IV insulin: Total daily requirement = 1.5 × 24 = 36 units. Using the 50/50 split: give 18 units basal insulin immediately, with 18 units divided as rapid-acting before meals (6 units per meal if eating three times daily).

Critical Timing Considerations for Early Morning Transitions (1am-4am)

If transitioning between 1am-4am, inject the basal insulin immediately upon stopping the IV infusion—do not delay. 1 The guideline specifically states "best time = 20:00 hrs" but emphasizes that if transition occurs at other times, you must:

1. Adapt the dose to the time of starting
2. Give the second injection at the preferred time (20:00 hrs) with the remaining total dose 1

For example, if transitioning at 2am with a calculated basal dose of 20 units total daily:

• Give approximately 8-10 units immediately at 2am (proportional to hours until evening dose)
• Give the remaining 10-12 units at 8pm that same day
• This prevents the gap in basal insulin coverage that leads to rebound hyperglycemia

Preventing Rebound Hyperglycemia

The most common pitfall is stopping IV insulin without immediately administering subcutaneous basal insulin. 3, 4 Patients become relatively insulin deficient within 1-2 hours of IV insulin discontinuation, leading to:

• Recurrent ketoacidosis (in type 1 diabetes or DKA patients) 3, 4
• Severe rebound hyperglycemia 5, 6

Basal insulin must be given 2-4 hours before stopping IV insulin in DKA/HHS cases to prevent recurrence of ketoacidosis 3, 4. However, in standard ICU transitions without active DKA, immediate administration at the time of IV insulin discontinuation is acceptable 1.

Insulin Type Selection

• Basal insulin: Long-acting analog (glargine, detemir, degludec) or NPH insulin 2, 4
• Prandial insulin: Rapid-acting analog (aspart, lispro, glulisine) given before meals 1, 2

For early morning transitions when the patient is NPO or sleeping: Use the basal-plus approach—give basal insulin immediately and use correction-dose rapid-acting insulin every 4-6 hours based on point-of-care glucose monitoring rather than scheduled prandial doses 2.

Monitoring Requirements

• Check blood glucose every 2-4 hours initially after transition 3, 4
• Target glucose 140-180 mg/dL (7.8-10.0 mmol/L) in most hospitalized patients 2
• Have correction insulin protocol available for glucose >180 mg/dL 2
• Monitor for hypoglycemia, particularly in patients at high risk (elderly, renal dysfunction, poor oral intake) 2, 7

Special Considerations

If IV insulin rate >5 units/hour: Leave IV infusion in place—this indicates severe insulin resistance requiring continued IV therapy 1

For patients on home insulin pumps: Reconnect the pump when patient is autonomous; if not autonomous, use the basal-bolus subcutaneous regimen described above 1

Weight-based dosing alternative: Recent evidence suggests 0.2-0.25 units/kg as basal insulin during IV infusion transition, followed by weight-based basal-bolus regimen, improves glycemic control at 24-48 hours without increasing hypoglycemia 5. This approach may be particularly useful when 24-hour IV insulin data is unavailable.